Patch for treating and alleviating symptoms of skin diseases accompanied by effusion of blood proteins

Abstract

Provided is a patch for treating skin diseases or alleviating symptoms of the skin diseases involving an exudation of blood proteins, or for absorbing blood proteins exuded to the skin.

1 . A patch for treating skin diseases or alleviating symptoms of the skin diseases involving an exudation of blood proteins, the patch comprising:
 a) a polymer matrix with a mesh structure; and   b) a polar resin bonding with proteins contained in the matrix and/or a resin bonding with proteins through a hydrophobic bonding.   
     
     
         2 . The patch for treating the skin diseases or alleviating the symptoms of the skin diseases according to  claim 1 , wherein the polymer matrix with the mesh structure is a micro-mesh structure of a complex carbohydrate selected from the group consisting of agar and agarose, or a micro-mesh structure produced by using polyacrylamide, latex, polystyrene, polyvinyl chloride, silicone polyurethane, or cellulose fiber. 
     
     
         3 . The patch for treating the skin diseases or alleviating the symptoms of the skin diseases according to  claim 1 , wherein the polar group is agarose, sephadex, or sepharose having DEAE (Diethylaminoethyl)-group; agarose, sephadex, or sepharose having CM (Carboxymethyl)-group; agarose, sephadex, or sepharose having trimethylammonium-group; a resin having a functional group, such as sulfonyl- or sulfonic acid derivatives as S-cation exchange resin; or a polar resin (charged resin) of hydroxylapatite granules or polystyrene structure. 
     
     
         4 . The patch for treating the skin diseases or alleviating the symptoms of the skin diseases according to  claim 1 , wherein the resin bonding with proteins through the hydrophobic bonding (hydrophobic interaction) is a resin containing C4 to C10 hydrocarbon chain. 
     
     
         5 . The patch for treating the skin diseases or alleviating the symptoms of the skin diseases according to  claim 1 , wherein the patch is prepared by multiply arranging the resins with different polarities. 
     
     
         6 . The patch for treating the skin diseases or alleviating the symptoms of the skin diseases according to  claim 1 , wherein the skin disease includes an atopic dermatitis, eczema, psoriasis, a contact dermatitis, erythema, Lichen, chronic or contact urticaria, nodlaris (prurigo nodlaris), and a slight burn or scald that does not damage the stratum corneum. 
     
     
         7 . The patch for treating the skin diseases or alleviating the symptoms of the skin diseases according to  claim 1 , wherein the patch further includes disaturated phospholipids, organic acids, and divalent cations. 
     
     
         8 . The patch for treating the skin diseases or alleviating the symptoms of the skin diseases according to  claim 1 , wherein the patch further includes triacylglycerol, seramide, seramide derivatives, complex lipids extracted from animals, or synthetic lipids. 
     
     
         9 . (canceled) 
     
     
         10 . A patch for treating skin diseases or alleviating symptoms of the skin diseases involving an exudation of blood proteins, the patch being prepared by directly fixing a functional group capable of bonding with proteins to a fabric, pad, or gauze. 
     
     
         11 . The patch for treating the skin diseases or alleviating the symptoms of the skin diseases involving the exudation of blood proteins according to  claim 10 , wherein the functional group includes DEAE-, CM-, trimethylammonium-, or sulfonic acid-group. 
     
     
         12 . The patch for treating the skin diseases or alleviating the symptoms of the skin diseases involving the exudation of blood proteins according to  claim 11 , wherein the functional group includes C4 to C10 as a length of a saturated hydrocarbon chain. 
     
     
         13 . (canceled) 
     
     
         14 . A patch for diagnosing skin diseases involving an exudation of blood proteins, the patch comprising:
 a) a polymer matrix with a mesh structure; and   b) a polar resin bonding with proteins contained in the matrix and/or a resin bonding with proteins through a hydrophobic bonding.   
     
     
         15 . (canceled)